|
|
Group without ovarian metastasis |
Group with ovarian metastasis |
p |
|
|
N (%) |
N (%) |
|
Family history of tumor |
No |
669 (87.57) |
20 (86.96) |
0.931 |
|
Yes |
95 (12.43) |
3 (13.04) |
|
Gross type |
Localized |
380 (73.22) |
9 (64.29) |
0.458 |
|
Diffuse |
139 (26.78) |
5 (35.71) |
|
Depth of muscular invasion |
No |
179 (25.98) |
2 (9.09) |
0.01 |
|
<1/2 |
350 (50.80) |
9 (40.91) |
|
|
≥1/2 |
160 (23.22) |
11 (50) |
|
Cytology of ascites |
Negative |
330 (89.67) |
5 (55.56) |
0.001 |
|
Positive |
38 (10.33) |
4 (44.44) |
|
Pathological type |
Endometrioid |
679 (88.99) |
18 (88.68) |
0.11 |
|
Special types* |
84 (11.01) |
5 (21.74) |
|
Grade of cell differentiation |
G1 |
252 (37.11) |
4 (19.05) |
0.028 |
|
G2 |
313 (46.10) |
9 (42.86) |
|
|
G3 |
114 (16.79) |
8 (38.10) |
|
Cervical metastasis |
No |
700 (91.62) |
15 (65.22) |
0 |
|
Yes |
64 (8.38) |
8 (34.78) |
|
Parametrial metastasis |
No |
739 (96.73) |
19 (82.61) |
0 |
|
Yes |
25 (3.27) |
4 (17.39) |
|
Vaginal metastasis |
No |
760 (99.48) |
22 (95.65) |
0.023 |
|
Yes |
4 (0.52) |
1 (4.35) |
|
Oviduct metastasis |
No |
746 (97.64) |
20 (86.96) |
0.002 |
|
Yes |
18 (2.36) |
3 (13.04) |
|
Ligament metastasis |
No |
753 (98.56) |
22 (95.65) |
0.262 |
|
Yes |
11 (1.44) |
1 (4.35) |
|
Vascular carcinoma embolism |
No |
733 (95.94) |
21 (91.3) |
0.274 |
|
Yes |
31 (4.06) |
2 (8.7) |
|
Lymphatic metastasis |
No |
750 (98.17) |
20 (86.96) |
0 |
|
Yes |
14 (1.83) |
3 (13.04) |
|
*Special pathological types include serous papillary adenocarcinoma, clear cell carcinoma and adenosquamous carcinoma |